If you are new to TikTikTalk ? Your first verification mail might be in your spam folder.Check there and move it to your inbox to complete registration or account verification process..
Patrocinado
sociofans

Cell & Gene Therapy Manufacturing Services Market worth $11.5 Billion

0
2K

The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. Growing prevalence of cancer and other other diseases, the surge in pharmaceutical R&D spending along with partnerships and agreements between pharmaceutical companies and CDMOs are some of the factors driving the market growth. On the contrary, the significant operational costs associated with cell and gene therapy manufacturing is expected to negatively impact the cell & gene therapy manufacturing market during the forecast period.

Request for Free Sample Report

Key Takeaways

  • The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027.
  • The cell therapy segment dominated the cell & gene therapy manufacturing services market in 2021.
  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Lonza (Switzerland), Catalent (US), Thermo Fisher Scientific (US), Charles River Laboratories (US), WuXi AppTec (China), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Cell and Gene Therapy Catapult (UK) are some of the key players in the cell & gene therapy manufacturing services market.

Market Drivers

  • Growing prevalence of cancer and other other diseases
  • Surge in pharmaceutical R&D spending
  • Partnerships and agreements between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Market Restraints

  • Significant operational costs associated with cell and gene therapy manufacturing
  • Stringent regulatory requirements
  • Lack of skilled professionals

Market Opportunities

  • Increasing demand for cell and gene therapies
  • Growing number of clinical trials for cell and gene therapies
  • Development of new cell and gene therapy technologies

Market Trends

  • Increasing adoption of cell and gene therapy manufacturing services by pharmaceutical and biotechnology companies
  • Growing focus on partnerships and collaborations between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Geographical Analysis

  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Europe is expected to be the second-largest market for cell & gene therapy manufacturing services market during the forecast period.
  • Asia Pacific is expected to be the fastest-growing market for cell & gene therapy manufacturing services market during the forecast period.

Company Profiles

  • Lonza (Switzerland)
  • Catalent (US)
  • Thermo Fisher Scientific (US)
  • Charles River Laboratories (US)
  • WuXi AppTec (China)
  • Merck KGaA (Germany)
  • Takara Bio Inc. (Japan)
  • Oxford Biomedica (UK)
  • Cell and Gene Therapy Catapult (UK)
  • Genezen (US)
  • FUJIFILM Holdings Corporation (Japan)
  • Nikon Corporation (Japan)
  • The Discovery Labs LLC (US)
  • RoslinCT (Scotland)
  • JRS Pharma (Germany)
  • FinVector (Finland)
  • ABL, Inc. (US)
  • Resilience (US)
  • BioCentriq (US)
  • Porton Advanced Solutions (China)
  • Andelyn Biosciences (US)
  • Forge Biologics (US)
  • Vibalogics (US)
  • Anemocyte Srl (Italy)
  • ElevateBio (US)

Speak to Analyst

Recent Developments

  • In 2021, Charles River Laboratories acquired a cell & gene therapy CDMO—Cognate BioServices—to increase its cell and gene therapy manufacturing capabilities.
  • In 2021, Thermo Fisher Scientific acquired Henogen S.A., Novasep's viral vector manufacturing business in Belgium, for approximately USD 859.7 million. This acquisition will increase its presence in the cell & gene therapy manufacturing therapy market.
  • In 2019, Thermo Fisher Scientific acquired Brammer Bio, a company engaged in viral vector manufacturing for gene and cell therapies, for USD 1.7 billion.

Top 10 Companies in the Tissue Diagnostics Market
Top 10 Companies in Human Capital Management Market
Top 10 Companies Leading the Patient Engagement Solutions Market
Top 10 Companies in the Blood Collection Devices Market

Patrocinado
Patrocinado
Pesquisar
Patrocinado
Categorias
Leia Mais
Networking
Healthcare Staffing Market 2024-2032 Report | Industry Share, Size, Growth Drivers, Current Trends
    What is the Healthcare Staffing Market? The Healthcare Staffing market involves...
Por amelia78 2024-04-24 15:51:16 0 2K
Outro
Smart City Platform Market latest Analysis and Growth Forecast By 2033
According to the Regional Research Reports, the global Smart City Platform market is...
Por marketstatsvillegroup 2024-07-12 12:08:45 0 2K
Outro
Wisata Fotografi di Tasikmalaya
Tasikmalaya, sebuah kota yang terletak di Provinsi Jawa Barat, dikenal dengan keindahan alamnya...
Por salsawisata 2024-06-26 08:43:53 0 2K
Outro
Hyperscale Data Center Market Growth, SWOT Analysis and Growth Prospects Till 2030
Market Analysis  The global hyperscale data center market size will touch...
Por Technews 2023-02-20 15:13:11 0 5K
Outro
Synthetic Natural Gas Market Global Size Report 2023-2030
The global market research study examines critical data such as market volume, industry...
Por Nick_Tech 2023-11-30 08:32:39 0 3K
Patrocinado